Abstract
After a long series of studies on the effects of neutron irradiation of 10B loaded neoplastic cells both in culture and in animal experiments, we started the clinical application of BNCT on humans affected by liver metastases of a radically resected colon adenocarcinoma. The procedure we adopted includes a first surgical phase, with hepatectomy; a radiotherapeutic phase, in which the isolated liver, washed and chilled, is extracorporeally irradiated with thermal neutrons; and then a second surgical phase for the reconnection of the liver to the patient. Until now two patients have been subjected to the BNCT treatment. The first one survived 44 months with a good quality of life, and died because of diffuse recurrences of his intestinal tumour. The second patient had the same early perioperative course, but after 33 days a worsening of a dilatative cardiomyopaty, from which he was suffering, determined a cardiac failure and eventually death. This clinical experience, although limited, has shown that extracorporeal neutron irradiation of the liver is a feasible procedure, able to ensure the complete destruction of liver metastases and a possible long lasting survival. In our patients neutron irradiation caused massive cellular necrosis highly specific to tumour cells, whereas normal cells were mostly spared. Nevertheless, the impact of such a traumatic operation on the patient's organism must be taken into account. Finally, we have to be aware that the fight against tumour rarely leads to a complete victory. We now have an innovative weapon which is both powerful and partly unsettled: it must be refined and above all used.
Export citation and abstract BibTeX RIS
References
- [1]Chiaraviglio D, De Grazia F, Zonta A, Altieri S, Braghieri A, Fossati F, Pedroni P, Pinelli T, Perotti A, Specchiarello M, Perlini G and Rief H 1989 Evaluation of selective boron absorption in liver tumors Strahlenther Onkol. 165 170-2
- [2]Pinelli T, Altieri S, Fossati F, Zonta A, Cossard D, Prati U, Roveda L, Ricevuti G and Nano R 1996 Development of a method to use boron neutron capture therapy for diffused tumors of liver (Taormina project) Neutron Capture Therapy for Cancer: Proc. 6thInt. Symp. (Kobe, Japan, 31 Oct-4 Nov 1994) ed Y Mishima (New York:Plenum) p 783-94
- [3]Pinelli T, Altieri S, Fossati F, Zonta A, Ferrari C, Prati U, Roveda L, Ngnitejeu Tata S, Barni S, Chiari P, Nano R and Ferguson DM 2001 Operative modalities and effects of bnct on liver metastases of colon adenocarcinoma. A microscopical and ultrastructural study in the rat Frontiers in Neutron Capture Therapy Proc. 8thInt. Symp. (Los Angeles, Ca, USA, 13-18 Sept 1998) ed MF Hawthorne et al (New York: Kluwer Academic/Plenum Publishers) p 1427-40
- [4]
- [5]Gray J W, Dolbeare F and Pallavicini M G 1990 Quantitative cell-cycle analysis Flow cytometry and sorting ed M R Melamed et al (New York:Wiley-Liss) chapter 23 p 445-67
- [6]Hill P R 1992 Cellular basis of radiotherapy The basic science of oncology ed I F Tannock and R P Hill (New York: McGraw-Hill) chapter 15 p 259-75
- [7]
- [8]Nano R, Barni S, Chiari P, Pinelli T, Fossati F, Altieri S, Zonta C, Prati U, Roveda L and Zonta A 2004 Efficacy of boron neutron capture therapy on liver metastases of colon adenocarcinoma. Optical and ultrastructural study in the rat Oncology Rep. 11 149-53
- [9]Roveda L, Prati U, Bakeine J, Trotta F, Marotta P, Valsecchi P, Zonta A, Nano R, Facoetti A, Chiari P, Barni S, Pinelli T, Altieri S, Braghieri A, Bruschi P, Fossati F and Pedroni P 2004 How to study boron distribution in liver metastases from colorectal cancer J. Chemoth 16 (Suppl. 5) 15-8
- [10]Pinelli T, Zonta A, Altieri S, Barni S, Braghieri A, Pedroni P, Bruschi P, Chiari P, Ferrari C, Fossati F, Nano R, Ngnitejeu Tata S, Prati U, Ricevuti G, Roveda L and Zonta C 2002 Taormina: from the first idea to the application to the human liver Research and development in Neutron Capture Therapy: Proc. 10thInt. Congress on Neutron Capture Therapy (Essen, Germany, 8-13 Sept 2002) ed W. Sauerwein et al (Bologna:Monduzzi) p 1065-72
- [11]Jaffe BM, Donegan WL, Watson F and Spratt JS Jr 1968 Factors influencing survival in patients with untreated hepatic metastases Surg. Gynecol. Obstet. 127 1-11
- [12]